SS Innovations International (SSII) Net Equity Issued and Repurchased (2016 - 2017)
SS Innovations International's (SSII) quarterly Net Equity Issued and Repurchased came in at $81185.0 in Q4 2017, up 13660.17% year-over-year from N/an in Q4 2016, and down 82.39% quarter-over-quarter from $461075.0 in Q3 2017.
Analysis
SS Innovations International (SSII) Net Equity Issued and Repurchased (2016 - 2017) Analysis & Trends
SS Innovations International has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $81185.0 for Q4 2017.
- In Q4 2017, Net Equity Issued and Repurchased rose 13660.17% year-over-year to $81185.0; the TTM figure through Dec 2018 stood at $542260.0 (down 19.93% YoY), while the FY2023 annual figure was $412056.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at $81185.0 for Q4 2017 at SS Innovations International, down from $461075.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $461075.0 in Q3 2017 to a low of $590.0 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | SS Innovations International | 682.58 Mn | 660.28 Mn | 7.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 81,185.00 |
| Sep 30, 2017 | 461,075.00 |
| Mar 31, 2017 | 135,000.00 |
| Dec 31, 2016 | 590.00 |